David Hung - 07 Jun 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Director
Signature
Steven Robbins, as attorney in fact for Hung, David
Issuer symbol
NVCR
Transactions as of
07 Jun 2023
Net transactions value
$0
Form type
4
Filing time
09 Jun 2023, 16:04:57 UTC
Previous filing
10 Jun 2022
Next filing
04 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Stock Option (Right to Buy) Award $0 +12,554 $0.000000 12,554 07 Jun 2023 Ordinary Shares 12,554 $48.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options to buy 12,554 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2024 annual general meeting of shareholders.